beta-Naphthylamine
|
CAS
91-59-8
|
C10H7NH2
|
RTECS
QM2100000
|
Synonyms & Trade Names
2-Aminonaphthalene, 2-Naphthylamine
|
DOT ID & Guide
1650 / 153
|
Exposure
Limits
|
NIOSH REL: Ca See Appendix A
|
|
OSHA PEL: [1910.1009] See Appendix B
|
IDLH
Ca [N.D.]
See: IDLH INDEX
|
Conversion
|
Physical Description
Odorless, white to red crystals with a faint, aromatic odor. [Note: Darkens in air to a reddish-purple color.]
|
MW: 143.2
|
BP: 583°F
|
MLT: 232°F
|
Sol: Miscible in hot water
|
VP(226°F): 1 mmHg
|
IP: 9.71 eV
|
|
Sp.Gr(208°F): 1.06
|
Fl.P: 315°F
|
UEL: ?
|
LEL: ?
|
|
|
Combustible Solid
|
Incompatibilities & Reactivities
None reported
|
Measurement Methods
NIOSH 5518; OSHA 93
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations (See Appendix E)
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Dermatitis; hemorrhagic cystitis; dyspnea (breathing difficulty); ataxia; methemoglobinemia, hematuria (blood in the urine); dysuria; [potential occupational carcinogen]
|
Target Organs
Bladder, skin
Cancer Site
[bladder cancer]
|
|
See also: INTRODUCTION
See MEDICAL TESTS: 0154
|
